An observational study of intermediate‐ or high‐dose thromboprophylaxis for critically ill COVID‐19 patients-Reference-Cited by-同舟云学术

An observational study of intermediate‐ or high‐dose thromboprophylaxis for critically ill COVID‐19 patients

Published:2021-12-16 Issue: Volume: Page:
ISSN:0001-5172
Container-title:Acta Anaesthesiologica Scandinavica
language:en
Short-container-title:Acta Anaesthesiol Scand

Author:

Jonmarker Sandra¹²^ORCID,Litorell Jacob²,Dahlberg Martin¹³^ORCID,Stackelberg Otto¹³⁴^ORCID,Everhov Åsa H.¹³^ORCID,Söderberg Mårten¹⁵^ORCID,Rubenson‐Wahlin Rebecka¹²^ORCID,Günther Mattias¹²^ORCID,Mårtensson Johan⁶⁷^ORCID,Hollenberg Jacob¹⁸^ORCID,Joelsson‐Alm Eva¹²^ORCID,Cronhjort Maria¹²^ORCID

Affiliation:

1. Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet Stockholm Sweden

2. Department of Anaesthesia and Intensive Care Södersjukhuset Stockholm Sweden

3. Department of Surgery Södersjukhuset Stockholm Sweden

4. Institute of Environmental Medicine Unit of Cardiovascular and Nutritional Epidemiology, Karolinska Institutet Stockholm Sweden

5. Department of Internal Medicine Södersjukhuset Stockholm Sweden

6. Department of Physiology and Pharmacology Section of Anaesthesia and Intensive Care, Karolinska Institutet Stockholm Sweden

7. Department of Perioperative Medicine and Intensive Care Karolinska University Hospital Stockholm Sweden

8. Department of Cardiology Södersjukhuset Stockholm Sweden

Publisher

Wiley

Subject

Anesthesiology and Pain Medicine,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aas.14013

Reference28 articles.

1. Thromboembolism risk of COVID‐19 is high and associated with a higher risk of mortality: a systematic review and meta‐analysis;Malas MB;EClinicalMedicine,2020

2. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid‐19;Ackermann M;N Engl J Med,2020

3. Pulmonary and cardiac pathology in African American patients with COVID‐19: an autopsy series from New Orleans;Fox SE;Lancet Respir Med,2020

4. COVID‐19 is, in the end, an endothelial disease;Libby P;Eur Heart J,2020

5. The hypercoagulable state in COVID‐19: incidence, pathophysiology, and management;Abou‐Ismail MY;Thromb Res,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet dysfunction and thrombus instability in flow conditions in patients with severe COVID-19;Thrombosis Research;2023-01

2. Kein Überlebensvorteil durch hoch dosierte Antikoagulation bei COVID-19-Patienten;Journal Club AINS;2022-09

3. Kein Überlebensvorteil durch hoch dosierte Antikoagulation bei COVID-19-Patienten;AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie;2022-06